Related Experiment Video
Updated: May 24, 2026
09:51
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
[Laparoendoscopic single-site retroperitoneal lymph node dissection: initial experience and 1-year follow-up]
Abai Xu1, Hulin Li, Shaobo Zheng
1Department of Urology, Southern Medical University, Guangzhou, China.
Summary
Laparoendoscopic single-site retroperitoneal lymph node dissection (LESS-RPLND) is a safe and feasible approach for nonseminomatous testicular cancer. This minimally invasive technique offers good cosmetic results and tumor control with preserved sexual function.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Context:
- Testicular cancer treatment often requires retroperitoneal lymph node dissection (RPLND).
- Traditional open or laparoscopic RPLND can be associated with significant morbidity.
- Laparoendoscopic single-site surgery (LESS) offers a minimally invasive alternative with potential cosmetic and recovery benefits.
Purpose:
- To evaluate the initial experience and feasibility of LESS-RPLND for nonseminomatous testicular cancer.
- To assess the safety, efficacy, and cosmetic outcomes of this novel surgical approach.
Summary:
- Three patients with nonseminomatous testicular cancer underwent LESS-RPLND using a homemade port and a nerve-sparing technique.
- The procedure was successfully completed in all cases with acceptable operative times and minimal blood loss.
- Histopathological examination revealed positive lymph nodes in one patient, who received adjuvant chemotherapy. All patients showed good tumor control and preserved sexual function at 1-year follow-up.
Impact:
- LESS-RPLND demonstrates potential as a safe and effective treatment option for select patients with nonseminomatous testicular cancer.
- The pararectal incision approach offers good cosmetic outcomes.
- Further large-scale studies are needed to confirm long-term efficacy and oncological control.
